Sort   by:  
 Page size 
UnknownLow-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma.
Not available
S-EPMC8776513 | biostudies-literature
UnknownTemsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
Not available
S-EPMC3690907 | biostudies-literature
UnknownPhase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
Not available
S-EPMC8647100 | biostudies-literature
UnknownLong-term survival in AIDS-related primary central nervous system lymphoma.
Not available
S-EPMC5193026 | biostudies-literature
UnknownPan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection.
Not available
S-EPMC8127360 | biostudies-literature
UnknownConsiderations when treating high-grade pediatric glioma patients with immunotherapy.
Not available
S-EPMC7880880 | biostudies-literature
UnknownOncogenic Kras drives invasion and maintains metastases in colorectal cancer.
Not available
S-EPMC5358757 | biostudies-literature
UnknownInhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model.
Not available
S-EPMC12016400 | biostudies-literature
UnknownPhase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma.
Not available
S-EPMC6039666 | biostudies-literature
UnknownMulticenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
Not available
S-EPMC3563362 | biostudies-literature
Sort   by:  
 Page size